Arrhythmic Risk and Treatment after Transcatheter Atrial Septal Defect Closure

Silvia Deaconu1, Alexandru Deaconu2,3, Gabriela Marascu2

  • 1ARES Centers, 021967 Bucharest, Romania.

PubMed

Insights

Atrial septal defect (ASD) closure can reduce arrhythmia risk, but complex mechanisms persist. Predicting and managing arrhythmias post-closure requires considering various clinical and device-related factors for optimal patient outcomes.

Area of Science:

  • Cardiology
  • Congenital Heart Disease
  • Electrophysiology

Background:

  • Atrial septal defect (ASD) is the most prevalent adult congenital heart defect.
  • Intracardiac shunts cause atrial and ventricular remodeling, increasing arrhythmia risk, particularly atrial fibrillation (AF).
  • Mechanisms of arrhythmia are complex, partly independent of hemodynamic overload.

Purpose of the Study:

  • To review predictors of atrial arrhythmias after ASD closure.
  • To discuss the impact of device closure and timing on arrhythmia risk.
  • To highlight sudden cardiac death (SCD) risk and implantable cardioverter-defibrillator (ICD) indications.

Main Methods:

  • Review of clinical, echocardiographic, and electrocardiogram predictors.
  • Assessment of device-related factors influencing arrhythmia risk.
  • Evaluation of mechanisms underlying arrhythmias post-ASD closure.

Main Results:

  • Clinical and device-related factors predict atrial arrhythmias post-closure.
  • ASD closure and its timing influence future arrhythmia risk.
  • Transseptal puncture post-closure presents procedural challenges.

Conclusions:

  • Risk stratification for arrhythmias after ASD closure is crucial.
  • Understanding complex underlying mechanisms is essential for management.
  • Selected patients may benefit from ICD implantation due to elevated SCD risk.